Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) General Information

Description

A small-molecule enzyme inhibitor developed for treating heparin-induced thrombocytopenia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Frederick, MD
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • Frederick, MD
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)‘s full profile, request access.

Request a free trial

Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)‘s full profile, request access.

Request a free trial

Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) FAQs

  • Where is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) headquartered?

    Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is headquartered in Frederick, MD.

  • What industry is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) in?

    Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)’s primary industry is Buildings and Property.

  • Is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) a private or public company?

    Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is a Private company.

  • What is the current valuation of Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)?

    The current valuation of Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is .

  • What is Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)’s current revenue?

    The current revenue for Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) is .

  • Who are Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)’s investors?

    Veralox Therapeutics has invested in Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland).

  • When was Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) acquired?

    Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) was acquired on 11-Dec-2025.

  • Who acquired Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland)?

    Veralox Therapeutics (VLX-1005 and 12-Lipoxygenase Assets in Frederick, Maryland) was acquired by Cadrenal Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process